Kidney cancer is a condition where abnormal cells grow in one or both kidneys. The most common type in adults is renal cell carcinoma. A diagnosis of kidney cancer can feel overwhelming, but treatment has advanced significantly over the years. Today, patients may be offered different treatment options depending on the stage of cancer, tumour size, cancer type, kidney function, overall health and whether the cancer has spread.
The main kidney cancer treatment options include surgery, targeted therapy and immunotherapy. In many cases, a combination of treatments may be recommended. Understanding these options can help patients and families have clearer discussions with their cancer care team.
Understanding Kidney Cancer Treatment Planning
There is no single treatment plan that suits every kidney cancer patient. Doctors usually begin by assessing the stage of the cancer. Early-stage kidney cancer may be limited to the kidney, while advanced kidney cancer may have spread to nearby lymph nodes, bones, lungs, liver or other organs.
Other important factors include the patient’s age, medical history, kidney function, symptoms, tumour location and whether the cancer is growing slowly or aggressively. The goal of treatment may be to remove the cancer, control its growth, reduce symptoms or improve quality of life.
At CuraLife Cancer Centre, treatment planning focuses on a personalised approach, where the care team considers both the cancer and the patient’s overall wellbeing.
Surgery for Kidney Cancer
Surgery is often one of the main treatment options for kidney cancer, especially when the tumour is found at an early stage or is limited to the kidney. The aim of surgery is to remove the cancer while preserving as much healthy kidney function as possible.
There are two common types of kidney cancer surgery:
Partial Nephrectomy
A partial nephrectomy, also called kidney-sparing surgery, removes only the tumour and a small amount of nearby healthy tissue. The rest of the kidney is left in place. This option may be considered when the tumour is small, when the patient has only one working kidney, or when preserving kidney function is especially important.
Partial nephrectomy may help reduce the risk of long-term kidney problems, but it depends on the size and location of the tumour.
Radical Nephrectomy
A radical nephrectomy removes the entire kidney and may also include nearby tissues, lymph nodes or the adrenal gland if required. This surgery may be recommended when the tumour is large, centrally located or not suitable for kidney-sparing surgery.
Many people can live with one kidney, but regular follow-up is important to monitor kidney function and overall health after surgery.
Surgery in Advanced Kidney Cancer
In some advanced cases, surgery may still be considered. For example, doctors may remove the kidney tumour to reduce cancer burden or manage symptoms. Surgery may also be used in selected cases where cancer has spread to a limited number of areas. However, if the cancer is widespread, systemic treatments such as targeted therapy or immunotherapy may be more suitable.
Targeted Therapy for Kidney Cancer
Targeted cancer therapy uses medicines that focus on specific pathways cancer cells use to grow and spread. Unlike traditional chemotherapy, targeted therapy is designed to interfere with certain cancer-related signals, including blood vessel growth and tumour growth pathways.
Kidney cancers, especially renal cell carcinoma, often rely on the development of new blood vessels to receive oxygen and nutrients. Some targeted therapies work by blocking these blood vessel signals, helping slow tumour growth.
Targeted therapy may be used for advanced kidney cancer, metastatic kidney cancer, or cancer that cannot be fully removed with surgery. It may also be used when cancer returns after initial treatment.
Common targeted therapy approaches may include medicines that block VEGF pathways, tyrosine kinase inhibitors or mTOR pathway inhibitors. The exact medicine depends on the cancer type, prior treatment, side effect profile and the patient’s general condition.
Targeted therapy can be effective, but it may cause side effects. These can include tiredness, high blood pressure, diarrhoea, skin changes, appetite changes, mouth sores or changes in liver and kidney function. Patients receiving targeted therapy need regular monitoring and supportive care to manage side effects safely.
Immunotherapy for Kidney Cancer
Immunotherapy helps the body’s immune system recognise and attack cancer cells. Kidney cancer is one of the cancers where immunotherapy has become an important treatment option, particularly for advanced or metastatic disease.
A common type of immunotherapy used in kidney cancer is immune checkpoint inhibitor therapy. These medicines help remove the “brakes” that prevent immune cells from attacking cancer. By improving the immune response, immunotherapy may help shrink tumours or slow cancer growth in some patients.
Immunotherapy may be used alone or in combination with another immunotherapy medicine or targeted therapy. Combination treatment is often considered for advanced kidney cancer, depending on cancer risk group, tumour type and patient suitability.
In some high-risk cases, immunotherapy may also be recommended after surgery to reduce the chance of cancer returning. This is known as adjuvant treatment.
Immunotherapy side effects are different from chemotherapy or targeted therapy. Because it activates the immune system, it can sometimes cause inflammation in healthy organs. Possible side effects may involve the skin, bowel, liver, lungs, thyroid or other hormone glands. Symptoms such as persistent diarrhoea, breathing difficulty, severe tiredness, rash or yellowing of the eyes should be reported promptly.
Choosing the Right Kidney Cancer Treatment
The best kidney cancer treatment depends on many factors. Some patients may need surgery only, while others may need targeted therapy, immunotherapy or a combination of treatments. For advanced kidney cancer, doctors may recommend systemic therapy to treat cancer cells throughout the body.
Important questions to ask the cancer care team include:
What stage and type of kidney cancer do I have?
Is surgery suitable for me?
Will part or all of the kidney need to be removed?
Do I need targeted therapy or immunotherapy?
What side effects should I expect?
How will treatment affect my daily life?
How often will I need follow-up scans and tests?
Asking these questions can help patients feel more informed and involved in their care.
Follow-Up Care After Kidney Cancer Treatment
Follow-up care is an important part of kidney cancer management. Even after successful treatment, regular check-ups may be needed to monitor kidney function, check for recurrence and manage long-term side effects.
Follow-up may include physical examinations, blood tests, urine tests, imaging scans and discussions about symptoms. Patients may also receive guidance on hydration, blood pressure control, nutrition, physical activity and protecting remaining kidney function.
Emotional support is also important. Many patients experience anxiety, fear of recurrence or lifestyle changes after treatment. Support from family, counsellors, support groups and the healthcare team can make recovery easier.
Kidney Cancer Care at CuraLife Cancer Centre
CuraLife Cancer Centre provides personalised cancer care for patients diagnosed with kidney cancer. From diagnosis and treatment planning to surgery support, targeted therapy, immunotherapy and follow-up care, the focus is on helping patients receive clear guidance at every stage.
If you or a loved one has been diagnosed with kidney cancer, speaking with an experienced oncology team can help you understand your treatment options and make informed decisions with confidence.
Early evaluation, the right treatment plan and regular follow-up can make a meaningful difference in kidney cancer care.
